Evidence map›Paper›PMID 29925793›Full record

ArticleViruses2018

Identification and Characterization of Type IV Pili as the Cellular Receptor of Broad Host Range

Jaclyn G McCutcheon, Danielle L Peters, Jonathan J Dennis

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 57 citations in OpenAlex.

  1. AApplied and environmental microbiology · 2026
    Article
  2. Article
  3. Article
  4. Therapeutic Potential of a NovelInternational journal of molecular sciences · 2026
    Article
  5. AFrontiers in microbiology · 2026
    Article
  6. Review
  7. Review
  8. OvercomingAntibiotics (Basel, Switzerland) · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Frontiers in microbiology · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. A guide toFrontiers in cellular and infection microbiology · 2023
    Review
  18. Article
  19. Biological Features and In Planta Transcriptomic Analyses of aInternational journal of molecular sciences · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jaclyn G McCutcheonCW405 Biological Sciences Building, 11455 Saskatchewan Dr. NW, Department of Biological Sciences, University of Alberta, Edmonton, AB T6G 2E9, Canada. jgmccutc@ualberta.ca.
Danielle L PetersCW405 Biological Sciences Building, 11455 Saskatchewan Dr. NW, Department of Biological Sciences, University of Alberta, Edmonton, AB T6G 2E9, Canada. dlpeters@ualberta.ca.
Jonathan J DennisCW405 Biological Sciences Building, 11455 Saskatchewan Dr. NW, Department of Biological Sciences, University of Alberta, Edmonton, AB T6G 2E9, Canada. jon.dennis@ualberta.ca.
University of Alberta · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteriophages DLP1 and DLP2 are capable of infecting both

Indexed as

Bacterial ProteinsBacteriophagesDrug Resistance, Multiple, BacterialFimbriae, BacterialFimbriae ProteinsGenetic Complementation TestHost SpecificityHumansMicroscopy, Electron, TransmissionMutationPhage TherapyPseudomonas aeruginosaPseudomonas PhagesReceptors, VirusStenotrophomonas maltophiliaVirulenceBacterial ProteinsFimbriae ProteinsReceptors, Virusbacteriophagephagephage receptorphage therapypilusPseudomonas aeruginosaStenotrophomonas maltophiliaType IV pili

Identifiers

PMID29925793
PMCPMC6024842
OpenAlexW2809663289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.